Chairman
Beta Drugs Limited
Equibles does not estimate personal net worth.
Rahul Batra is recorded as Chairman at Beta Drugs Limited. Rahul Batra has spoken on 2 earnings calls across 1 company, most recently for Beta Drugs Limited on October 22, 2026. Beta Drugs Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“On behalf of Beta Drugs family, we wish you all a very happy Diwali. To start with, let me take you to the key financial highlights. The revenue growth of Beta is at 29.2% as compared to H1 F526.”
“Let me take you to the key highlights of FY26. First, coming on to the financial analysis. Vita's net revenue grew from 368 crores to 396 crores. The gross margin grew from 52.71% to 55.52%.”
Beta Drugs Limited
Chairman
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Earnings Call
Beta Drugs Limited
Earnings Call
Beta Drugs Limited
